Valuation Bristol-Myers Squibb Company

Equities

Market Closed - Nyse Other stock markets 21:00:02 17/02/2026 GMT			5-day change	1st Jan Change
60.35 ^USD	-0.64%		-0.84%	+11.88%

02-17	Mubadala Investment Co PJSC reports share stake in Pfizer, AbbVie, dissolves in Merck, Dell	RE
02-17	U.S. FDA accepts Bristol Myers Squibb's NDA for iberdomide in multiple myeloma	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	138,395	159,703	104,403	114,714	109,809	122,901	-	-
Change	-	15.4%	-34.63%	9.88%	-4.28%	11.92%	-	-
Enterprise Value (EV) ¹	165,982	189,770	131,531	153,184	143,852	148,713	143,473	136,594
Change	-	14.33%	-30.69%	16.46%	-6.09%	3.38%	-3.52%	-4.79%
P/E ratio	20x	24.4x	13.3x	-12.8x	15.6x	12.3x	12.9x	14.1x
PBR	3.73x	5.02x	3.48x	6.95x	5.94x	5.08x	4.55x	4.13x
PEG	-	-4.48x	0.4x	0x	-0x	0.3x	-2.98x	-1.65x
Capitalization / Revenue	2.98x	3.46x	2.32x	2.38x	2.28x	2.63x	2.72x	3.04x
EV / Revenue	3.58x	4.11x	2.92x	3.17x	2.98x	3.18x	3.18x	3.38x
EV / EBITDA	8.1x	9.83x	7.52x	25.8x	7.71x	8.86x	8.53x	9.21x
EV / EBIT	8.37x	9.76x	7.84x	29.4x	9.83x	9.24x	9.2x	9.91x
EV / FCF	10.9x	15.9x	10.4x	11x	11.2x	10.1x	10.5x	10.7x
FCF Yield	9.18%	6.3%	9.62%	9.1%	8.93%	9.95%	9.5%	9.36%
Dividend per Share ²	2.01	2.19	2.31	2.42	2.49	2.524	2.61	2.688
Rate of return	3.22%	3.04%	4.5%	4.28%	4.62%	4.18%	4.32%	4.45%
EPS ²	3.12	2.95	3.86	-4.41	3.46	4.902	4.69	4.288
Distribution rate	64.4%	74.2%	59.8%	-54.9%	72%	51.5%	55.6%	62.7%
Net sales ¹	46,385	46,159	45,006	48,300	48,194	46,695	45,156	40,418
EBITDA ¹	20,493	19,308	17,498	5,932	18,649	16,787	16,829	14,839
EBIT ¹	19,830	19,442	16,785	5,204	14,638	16,090	15,600	13,788
Net income ¹	6,994	6,327	8,025	-8,948	7,054	10,033	9,332	8,527
Net Debt ¹	27,587	30,067	27,128	38,470	34,043	25,812	20,572	13,693
Reference price ²	62.35	71.95	51.31	56.56	53.94	60.35	60.35	60.35
Nbr of stocks (in thousands)	2,219,645	2,219,645	2,034,758	2,028,177	2,035,753	2,036,474	-	-
Announcement Date	04/02/22	02/02/23	02/02/24	06/02/25	05/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BRISTOL-MYERS SQUIBB COMPANY	12.39x	3.2x	8.91x	4.16%	124B
ELI LILLY AND COMPANY	31.13x	11.79x	23.7x	0.63%	929B
JOHNSON & JOHNSON	24.78x	6.01x	16.37x	2.18%	587B
ABBVIE INC.	64.64x	7.64x	18.92x	2.82%	409B
ROCHE HOLDING AG	18.94x	4.72x	11.7x	2.78%	375B
ASTRAZENECA PLC	32.58x	5.84x	17.41x	1.57%	320B
NOVARTIS AG	21.67x	6.05x	14.9x	2.67%	314B
MERCK & CO., INC.	15.68x	5.03x	10.97x	2.66%	301B
NOVO NORDISK A/S	14.67x	5.07x	10.67x	3.53%	217B
AMGEN INC.	24.95x	6.3x	11.12x	2.72%	199B
Average	26.14x	6.16x	14.47x	2.57%	377.52B
Weighted average by Cap.	28.78x	7.26x	16.67x	2.13%